Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

Wildflower is a holistic wellness company headquartered in Vancouver building reputable brands and quality products that incorporate the synergistic effects of plants and their extracts.

World-Class is an innovation-driven company with a principle focus on the rapidly evolving cannabis and hemp industries. World-Class offers compliant and secure delivery of government regulated products through its subsidiary Pineapple Express Delivery Inc., including medical and recreational cannabis in Ontario, Manitoba and Saskatchewan, and liquor delivery in certain jurisdictions in Saskatchewan.  World-Class continues to investigate opportunities to deploy and manage custom-built extraction centres utilizing its custom systems, technology, and processes to efficiently produce high-quality cannabis and hemp concentrates and end-products.

WPD Pharmaceuticals is a biotechnology research and development company. The Company operates in the pharmaceuticals industry with a focus on oncology, namely research and development of medicinal products involving biological compounds and small molecules. The Issuer is developing drugs which were researched at institutions including MD Anderson Cancer Center, Mayo Clinic and Emory University, and has ongoing collaborations with Wake Forest University and leading hospitals and academic centers in Poland.

XORTX Therapeutics Inc. is a biopharmaceutical company with three clinically advanced products in development – XRx-008 for Autosomal Dominant Polycystic Kidney Disease (ADPKD), XRx-101 for Coronavirus / COVID-19 infection in addition to ongoing in licensing activity relating to potential therapies for Type 2 Diabetic Nephropathy (T2DN). The Company has strong intellectual property rights and established proof of concept through independent clinical studies. XORTX is working to advance its clinical development stage products that target xanthine oxidase to inhibit production of uric acid. At XORTX Therapeutics, we are dedicated to developing medications to improve the quality of life and future of patients.

XPhyto Therapeutics Corp. (“XPhyto”) is a bioscience accelerator focused on next-generation drug delivery, diagnostic, and new active pharmaceutical ingredient investment opportunities, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active pharmaceutical ingredients for neurological applications, including psychedelic compounds and cannabinoids. The Company has research and development operations in North America and Europe, with an operational focus in Germany, and is currently focused on regulatory approval and commercialization of medical products for European markets.

Through its subsidiaries in China, Japan and the United States, Yooma intends to leverage the success and experience of its senior management and board of directors to build Yooma's business into a global leader in the marketing, distribution and sale of wellness products including hemp seed oil and hemp-derived and cannabinoid (CBD) products through strategically curated network of sales channels. Yooma has assembled a strong international team of multicultural industry professionals with extensive experience in digital marketing, ecommerce and social media in EU, North America, and the pan-Asian region with particular depth in the Chinese ecommerce market.

Contact The Team

How can we help you?

Contact the CSE team to find out more.

Advertisement

Publicité

Latest CSE News

Upcoming Events

2021-06-23-Psychedelics-Now-Virtual-Conference_Website.jpg

Psychedelics Now Virtual Conference

Wednesday, June 23, 2021 -
1:00pm to 5:30pm

Advertisement

Publicité